Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice

International Journal of Cardiology

Volumn 124, Issue 2, 2008, Pages 244-246

  Mair, Johannes ^a   Gerda, Falkensammer ^a   Renate, Hiemetzberger ^a   Ulmer, Hanno ^a   Andrea, Griesmacher ^a   Pachinger, Otmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

B type natriuretic peptide; Direct comparison; N terminal proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRIMARY HEALTH CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38649100603     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.230     Document Type: Article

References (11)

1. Doust J., Glasziou P., Pietrzak E., and Dobson A. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure (review). Arch Intern Med 164 (2004) 1978-1984
2. Mair J., Hammerer-Lercher A., and Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure patients. Clin Chem Lab Med 39 (2001) 571-588
3. Richards M., Nicholls M.G., Espiner E.A., et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47 (2006) 52-60
4. Masson S., Latini R., Anand I.S., et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-Heft) data. Clin Chem 52 (2006) 1528-1538
5. Levey A.S., Bosch J.P., Leweis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
6. Collinson P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. Analytical performance of the N terminal pro B-type natriuretic peptide assay on the Elecsys 1010 and 2010 analyzers. Eur J Heart Fail 6 (2004) 365-368
7. Rawlins M.L., Owen W.E., and Robets W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 123 (2005) 439-445
8. Hess G., Runkel S., Zdunek D., and Hitzler W.E. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors. Clin Chim Acta 360 (2005) 187-193
9. Hammerer-Lercher A., Puschendorf B., and Mair J. B-type natriuretic peptides as powerful markers in cardiac diseases - analytical and clinical aspects. J Lab Med 30 (2006) 165-184
10. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
11. Luchner A., Hengstenberg C., Loewel H., Riegger G.A.J., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide and N-terminal proBNP. Hypertension 46 (2005) 118-123